Skip to main content
Livermore
Livermore
ZHEN

Nurix Therapeutics, Inc.

NRIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001549595

In the last 90 days, Nurix Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 211 institutions reported holding it in 13F filings for Q2 2026, worth $2.84B in total; ARK Invest is the only superinvestor holding it.

Q4 2024 vs. Q3 2024

How the institutions holding Nurix Therapeutics, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of NRIX: Q3 2024 compared with Q4 2024
MeasureQ3 2024Of which not filed for Q4 2024Q4 2024Change
Holders1722175+5
Shares67.9M73.1K81.1M+13.3M (+19.6%)
Value$1.53B$1.54M$1.53B+$3.94M (+0.3%)

2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (36)

Institutions that held Nurix Therapeutics, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to NRIX in Q4 2024
InstitutionSharesValue% of portfolio
Ra Capital Management, L.P.1,333,333$25.1M0.33%
Point72 Asset Management, L.P.872,959$16.4M0.05%
Boxer Capital Management, LLC563,067$10.6M0.90%
Perceptive Advisors LLC330,614$6.23M0.17%
Jacobs Levy Equity Management, Inc229,369$4.32M0.02%
Darwin Global Management, Ltd.163,681$3.08M0.29%
Springhill Fund Asset Management (HK) Co Ltd160,500$3.02M4.91%
First Trust Advisors LP135,903$2.56M0.00%
Cubist Systematic Strategies, LLC124,025$2.34M0.04%
Velan Capital Investment Management LP97,889$1.84M1.59%
Jump Financial, LLC74,619$1.41M0.03%
Raymond James Financial Inc54,453$1.03M0.00%
Polymer Capital Management (HK) LTD50,098$943.8K0.17%
Verition Fund Management LLC31,396$591.5K0.00%
Bryce Point Capital, LLC28,564$538.1K0.16%
NEOS Investment Management LLC22,557$425.0K0.01%
Tema ETFs LLC22,557$425.0K0.18%
Brevan Howard Capital Management LP21,495$405.0K0.01%
Freestone Grove Partners LP16,724$315.1K0.00%
Police & Firemen's Retirement System of New Jersey15,582$293.6K0.00%
EntryPoint Capital, LLC14,105$265.7K0.11%
HSBC Holdings PLC12,107$226.0K0.00%
KLP Kapitalforvaltning AS11,100$209.1K0.00%
ADAR1 Capital Management, LLC11,000$207.2K0.04%
Nomura Holdings Inc10,514$198.1K0.00%
BNP Paribas Arbitrage, SA8,700$163.9K0.00%
Aquatic Capital Management LLC4,610$86.9K0.00%
GF Fund Management Co. Ltd.1,487$28.0K0.00%
Creative Planning1,028$19.4K0.00%
Aster Capital Management (DIFC) Ltd238$4.48K0.00%
Skopos Labs, Inc.35$6600.00%
EverSource Wealth Advisors, LLC33$6220.00%
Amundi17$3320.00%
J.Safra Asset Management Corp15$2800.00%
Caitong International Asset Management Co., Ltd13$2450.00%
IFP Advisors, Inc6$1130.00%

Sold out (31)

Institutions that held Nurix Therapeutics, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of NRIX in Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Boxer Capital, LLC563,067$12.7M
Renaissance Technologies LLC246,400$5.54M
Voloridge Investment Management, LLC241,048$5.42M
StemPoint Capital LP203,015$4.56M
EAM Investors, LLC174,760$3.93M
Jane Street Group, LLC157,619$3.54M
Susquehanna Portfolio Strategies, LLC154,044$3.46M
Hudson Bay Capital Management LP125,000$2.81M
Acadian Asset Management LLC106,861$2.40M
Boothbay Fund Management, LLC69,134$1.55M
Duquesne Family Office LLCSuperinvestorDuquesne Family Office44,200$993.0K
Polar Asset Management Partners Inc.27,000$606.7K
Los Angeles Capital Management LLC26,544$596.4K
Engineers Gate Manager LP24,975$561.2K
Dynamic Technology Lab Private Ltd23,578$530.0K
Tudor Investment Corp Et Al22,259$500.2K
Campbell & CO Investment Adviser LLC22,056$495.6K
Y-Intercept (Hong Kong) Ltd15,388$345.8K
Gsa Capital Partners LLP10,667$240.0K
Fernwood Investment Management, LLC9,681$217.5K
International Assets Investment Management, LLC4,494$200.0K
Great West Life Assurance Co4,876$110.0K
Steward Partners Investment Advisory, LLC4,050$91.0K
Quarry LP2,500$56.2K
Simplex Trading, LLC832$18.0K
TD Waterhouse Canada Inc.282$6.22K
Reuter James Wealth Management, LLC67$1.50K
Larson Financial Group LLC24$539
Lindbrook Capital, LLC19$427
Capital Performance Advisors LLP18$404
True Wealth Design, LLC15$338

Not filed for Q4 2024 yet (2)

Institutions that held Nurix Therapeutics, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding NRIX in Q3 2024 that haven't filed for Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
ClariVest Asset Management LLC63,149$1.32M
PEAK6 Investments LLC10,000$224.7K